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Abstract : The peptides Boc Phe-APhe-Phe-APhe-Phc-OCH^ (l) and Ac-APhe-Phe- 
Ala-APhe-Val-OCH} (II) were synthesized to determine the patterns of conformations in 
solutions of the sequences containing more than one APhe-residues The conformational 
investigations were carried out using 400 MHz and 500 MHz NMR spectroscopy. The 
deductions were based on the intramolecularly hydrQgen bonded NH groups and Nucleai 
Overhausei Effect (NOE) studies The temperature and solvent dependence studies were 
performed in (CD3 )2SO and CDC^-tCD-^SO mixture. The results of these investigations 
indicate that the peptides (I) and (II) adopt similar conformations. The conformations of the 
peptides are also found to be identical in both CDCI3 and (CDjJjSO. The observations further 
indicated the presence of three intramolecular hydrogen bonds of the type (1 + 3) -» 1 in both 
peptides with a resulting 3 ig-helical conformation These results clearly confirm that the 
sequences of APhe residues separated by one or more saturated residues adopt a 3 10-helical 
conformation in solution
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1. Introduction
The role of a,/J-dehydro-residue$ in the design of specific peptide structures is fast 
becoming a useful tool as definite trends are emerging for the dehydro-residue based 
conformations. A dehydro-residue introduces strong constraints which allow the formation 
of only a few specific conformations in peptides [1-43]. The magnitude ot constraints 
caused by a dehydro-residue is dependent on the size and geometry ot its side chain.
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According 10 the magnitude of constraints, the dehydro-residues can be divided into three 
broad categories :
(i) the residues whose side chains do not branch at such as Phe, Leu, Trp, Tyr etc 
adopt only three possible conformations which correspond to three sets of (0, y/) 
torsion angles centred at -60, 140; 80, 0 and -60, -30° and their enantiomeric 
structures [3-38],
(ii) the residues, in which the branching occurs at atom such as Val and lie, produce 
the strongest stcric effects with (0, y/) torsion angles centred at ± 60, ± 30° [39],
(iii) the AAla with-CH2 as the side chain induces mild steric effects and adopts an 
extended conformation with 0, y/ torsion angles centred at ± 180, ± 180° [40,42].
The peptides containing dchydro-residues of category (i) have been extensively 
studied [1-38]. The constraints introduced by these dehydro-residucs favour the formation 
of a p-turn II conformation when substituted at (/ + 2) position of a tetrapeptide [15-28]. 
The incorporation of these residues in peptides at (i + I) position also producesja |}-turn II 
conformation if the (/ + 2) position of the sequence has a flexible Gly or Ala residue [1-3, 
7] whereas, a bulky residue at (i -t- 2) position forces the peptide to adopt an alternating 
right-handed and left-handed 5-shaped conformation with (0, y/) torsion angles centred at 
± 50, ± 40° [i 1-14]. If there are more than one dehydro-rcsidues separated by one or more 
saturated residues, the resulting conformation is a 3|0-hehx [29-36]. These rules are based 
on the investigations carried out in the crystalline stale [3-38]. Such a generalisation has not 
yet been obtained in the solution state where only limited data arc available (43-47]. 
Therefore, we have synthesized the Boc Phc-APhe-Phe-APhe-Phe-OCH3 (1) and Ac- 
APhe-Phe-Ala-APhe-Val-OCH^ (II) and analysed their conformations in solution using 
2-dimensional NMR. *
2. Experimental procedures
2.1 .  P e p t i d e  s y n t h e s i s  :
The peptides were synthesized in solution phase using azlactone method [48,49]. The 
reactions were monitored by thin layer chromatography using (a) and (b) solvent systems . 
(a) Chloroform (CHCI3) : Methanol (MeOH) = 9 : 1; (b) rc-Butanol (rc-BuOh) : Acetic acid 
(AcOH) : H?0  = 4.5 : 0 .5 .0.5.
2 .1 .1 .  P e p t i d e  1 :
2.0 g Boc-Phe-OH was reacted with 1.6 g of /?-phenyl serine using 0.84 ml of 
/V-methylmorpholine (NMM) and 0.98 ml of isobutylchlorolormate (IBCF). 11.31 ml of 
NaOH was used to neutralise /J-Phenyl serine. The reaction mixture was worked up and
2.2 g of Boc-Phe-/J-Phenyl serine was obtained which gave RP1 = 0.69, Yield = 76%. Boc 
Phe-/J-Phcnyl serine (3.12 g) was converted to Boc-Phe-APhe-azlactone using 0.62 g of 
sodium acetate and acetic anhydride with RP = 0.90; Yield = 75%. Boc-Phe-APhe- 
azlactone was hydrolysed using 1 equivalent NaOH at pH 8 to Boc-Phe-APhe-OH. 1.4 g of
Boc-Phe-APhe-OH was coupled with M g  of L-Phe-OMe.HCl (ncutrallised with 0.56 ml 
NMM) by mixed anhydride method using 0.37 ml of NMM and 0.45 ml of IBCF. After 
work up and isolation, the powder like compound Boc-Phe-APhe-Phe-OCH3 (A) was 
obtained on evaporation of the ethylacetate layer. Rf° = 0.69, Rf* = 0.90; Yield = 60%; 
M.P. = 132°C.
2.0 g of Boc-Phe-APhe-Phe-OCH3 (A) was deprotectcd using 1.4 ml TFA/DCM 
mixture (1 : 1) for 45 minutes. Excess DCM and TFA were removed under vacuum. The 
residual mixture was triturated with diethylether and kept in the refrigerator and a while 
precipitate was decanted and dried to yield-2.24 g of TFA-Phe-APhe-Phc-OCH3 (B).
1.2 g of Boc-Phe-APhe-OH was dissolved in tetrahydrofuran and 0.32 ml of NMM 
and 0.38 ml of IBCF were added to the solution and the reaction mixture, stirred at -10°C 
in an ice salt bath for 20 minutes. 1.7 g of TFA-Phe-APhe-Phe-OCH3 was dissolved in THF 
and neutralised with 0.4 ml NMM and added to the reaction mixture with stirring at 0°C for
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Figure 1(a). 500 MHz *HNMR spectrum of Peplide(I) in CDC13
two hours and at room temperature overnight. The THF was removed under vacuum and 
residual mixture was washed with water, 10% sodium bicarbonate, 5% citric acid. The 
ethylacetate layer was dried over anhydrous sodium sulphate for two hours. The 
ethylacetate layer was evaporated to give 1.0 g of required peptide. RP* = 0.65, Rf^ = 0.75, 
Yield = 50%. The NMR spectral assignments for this peptide as observed in CDCI3 
(Figure la) and in (CDj^SO (Figure lb) are given in Table 1.
2.7.2. Peptide II:
N-Ac-APhe-OH or a-acetoamido cinnamic acid was coupled with L-Phe-OMe by mixed 
anhydride method. 2.0 g of N-Ac-APhe-OH (9.0 mmol) was dissolved in THF and coupled
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with L-Phe-OMe (obtained by neutralising HCl-Phe-OMe with 1.25 ml of NMM) using 
1.08 ml NMM and 1.26 ml of IBCF as described earlier. THF was removed from the 
reaction mixture under vacuo. The residual solution was dissolved in ethylacetate and 
washed with water, 10% sodium bicarbonate and 5% citric acid. The ethylacetate layer was
dried over sodium  su lphate overnight. 1.8 g o f N-Ac-APhe-Phe-OCH^ was acquired 
on evaporation of ethylacetate layer. This peptide was hydrolysed using 1 equivalent NaOH
Tabli* 1. Spectral assignments o f peptides I and 11
(a) Peptide Boc-Phe-A-Phe-Phe-A Phe-Plic-OCH3 (I)
residue No. 1 2  3 4 5
NH
Chemical shifts S (ppm) 
C“ H c Ph
CDClj 4.85 4 17 2.81-3.01
Phe 1 DMSO 7.07 4 30 2 95
CDCI3 7.72 - 7.15
APhe2 DMSO 9.79 - 7 02
CDCI3 7 13 4.69 3.11
Phe3 DMSO 8.32 4.76 3.16
CDCI3 8.75 - 6.97
APhe4 DMSO 9 69 - *
CDCI3 7 30 4.92 3.22
Phe5 DMSO 8.17 4.55 3.08
Table 1. (Cant'd.)
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(a) Peptide 
residue No
Boc-Phe-A-Phe-Phc-A-Phe-Phe-OCH3 (I) 
l 2 3 4 5
NH
Chemical shifts S (ppm) 
C“ H C^H
(b) Peptide 
residue No.
N-Ac-A*Phe-Phe-Ala-A-Phe-Val-OCH3 (U) 
1 2  3 4 5
CDCI3 8.97 - 6.17
APhel DM SO 9.82 - 6.60
CDCI3 8.16 4.30 3.31-3.17
Phe2 DMSO 8.36 4.53 3.02-3 13
C D Q 3 7.75 4 58 1 . 1 2
Ala3 DMSO 8.08 4 54 1.26
CDCI3 8 68 - 6 75
APlie4 DMSO 9 57 - 7 78
CDCI3 7.40 4.54 2.25
Val5 DMSO 7.78 4 50 2 19
* the resonance was not resolved.
(pH 8.0). 1.2 g of N-Ac-APhc-Phe-OH were obtained. Yield = 53%, Rfb = 0.86. 2.0 g Boc- 
Ala-OH was coupled with 2.3 g DL-Threo-/3-Phenylserine (neutrallised with 1 eq NaOH) 
using 1.2 ml NMM and 1.4 ml IBCF. After washing 3.0 g of Boc-Ala-0-Phenylserine was 
isolated. RP* = 0.52; Yield = 96%.
2.0 g of (J-Phcnylscrine was dissolved in acetic anhydride and treated with 0.86 g 
sodium acetate to yield 2.0 g of Boc-Ala-APhc-azlactone. 2.0 g Boc-Ala-APhe-azlactone 
was hydrolysed using 5 ml of NaOH to give 3.8 g of Boc-Ala-APhe-OH after washing the 
reaction mixture and upon evaporation of the ethylacctatc layer. 1.86 g of Boc-Ala-APhe- 
OH was coupled with 2.0 g of L-Val-OMe. HC1 (neutralised with 0.7 ml NMM) using 
0 6 ml NMM and 0.7 ml IBCF by mixed anhydride procedure as described above. 2.0 g of 
the desired peptide was obtained after working up the reaction mixture as described in 
pievious steps. Rf*1 = 0.9; Yield = 89%.
1.5 g of Boc-Ala-APhe-Val-OCH, was deprotccted on treatment with 3 ml of (1 ; 1) 
DCM/TFA mixture for 40 minutes at room temperature. The excess TFA and DCM were 
removed on the rotatory evaporator. The oily residue was triturated with anhydrous 
dicthylether and kept in the refrigerator. White solid product was decanted and dried. The 
yield of the TFA salt was 1.4 g.
0.6 g of N-Ac-APhc-Phe-OH was dissolved in THF and 0.19 ml of NMM and
0.24 ml of IBCF were added at -10 'C  with stirring for 20 minutes. 0.98 g of TFA-Ala- 
APhe-Val-OCHj neutralised with 0.24 ml NMM was then added to the reaction mixture and
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stirred at O’C tor 2 hours and at room temperature overnight. THF was removed from the 
reaction mixture and the residual solution was dissolved in ethylacetate and the ethylacetate
co
Figure 1(c). S00 MHz 'UNMR speciium of Peptide(II) in CDC13
layer was washed with water, 10% NaHCO and 5% citric acid. 0.5 g of N-Ac-APhe- 
Phe-Ala-APhe-Val-OCH3 was obtained on evaporation of the ethylacetate layeij. R fl = 0.57,
* 5 .
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Figure 1 (d). 500 MHz ’HNMR spectrum of Pcptide(ll) in (CDj^SO •
Rp» = 0.93, Yield = 41%. The NMR spectral assignments as observed in CDCI3 (Figure 1c) 
and (C D ^SO  (Figure Id) are given in Table 1.
2.2. NMR spectroscopy :
The samples were prepared from lyophilised peptides by dissolving in CDCl3 or (CD^SO. 
The peptide concentrations used were 10111M. The 'H NMR spectra for these peptides were 
obtained on Bruker AMX-400 MHz and Brukcr AM-500 MHz machines. The phase 
sensitive 2D NMR experiments were employed for assignments and for secondary structure 
elucidation. The 2D NMR spectra were recorded for 512 t\ values with 1024 complex 
points for each free induction decay. 32 scans per t { point were taken. Both +ve and -ve 
cross peaks were plotted without discrimination in all DQF COSY [50], NOESY [51] and
1
ROESY [52] spectra. For NOESY experiments the mixing time of 400 ms was used and the
r
ROESY experiments were carried out using a mixing time of 300 ms. The data were 
processed by zero filling cox to IK. The raw data were multiplied with suitable window 
functions i.e. phase sensitive sine bell in both dimensions.
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3. Results and discussion
3. /. Conformational analysis :
3. I. 1. Spectral assignments
Due to the presence of all Phe residues in (I), the sequential NOEs (Figures 2a, 2b, 2c, 2d) 
were helpful to distinguish the peaks of various pairs of protons. Both APhe2 and APhe4 
NHs were easily distinguishable as singlets in the low Field region as the C° proton in a 
dehydro-residue is absent. The APhe protons were not easily distinguishable as they are 
close to the amide proton region. The Phel NH appears at a relatively high field position 
(4.25 ppm) because it is being protected by the Boc group and the urethane linkage [531 
(It shifts to 7.08 ppm is (CD3)2 SO). The APhe2 NH was assigned by virtue of the sequential
8
6(ppm )
6 (ppm)5 * 3
Figure 2(a). NH-Ca H region of 500 MHz 2D-ROESY spccirum of Pcptidc(i) in COCl3
NOE with Phel C“H thus the other APhe NH singlet was assigned as APhe4 NH. The C“ 
proton showing an NOE to it is Phe3 C°H and the corresponding amide is Phe3 NH and the 
only unassigned NH is Phe5 NH (Figures 2a, 2b, 2c, 2d). Similarly, the assignments were 
made in (CDjfcSO. The similar procedure was used to assign lor peptide II using sequential 
NOEs (Figures 3a, 3b, 3c, 3d) in both CDC13 and (CD^SO.
3.1.2. Analysis of the NOE data :
Rotating frame NOESY (ROESY) experiments were performed as the intensity of the cross 
peaks in a NOESY spectra arc very weak due to the (Otc = 1 condition for small peptides. 
The NOEs for peptides arc a population weighted average of the NOEs in all the
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conformational states available to the peptide. For short peptides in solution the d^N 
(i, i + l )  distance becomes short enough to give observable NOEs between residues with 0 
and \|/ angles in the helix region of ftp, 0) space. The d w  distance does not vary much in the
Figure 2(b). NH -NH region of 500 MHz 2D-ROESY spectrum of Peptide(l) in CDCI3 .
allowed range of <p, y/torsion angles in this region. Thus the differences iivthe NfH. ,.NI+ jH 
NOEs reflect the difference in the population of conformer of helical <pr y/ values. The 
. .NH, + | type connectivities used for sequential assignments are indicative of unfolded 
conformations of the peptides. The observation of equally strong NfH ...N l+ |H NOEs is 
immediately indicative of folded conformations. The observation of medium range NOEs 
dan (i, i + 2), daw (i, 1 + 3), d ^  (i, i + 4), dap (i, i + 4) are strong indications of helical 
conformations [54]. But in very small peptides such as the ones discussed here, these NOEs 
are rare because of their small sequences. In such cases the NOE data needs support from 
the amide accessibilty experiments in order to probe the hydrogen bonding scheme of these 
peptides.
A. Boc-Phe-APhe-Phe-APhe-Phe-OCH3 (I)
(i) In C D C lj:
The presence of N,H.. .N,+ ,H NOEs (Table 2) between amides of all the residues indicated 
that the peptide was predominantly helical in nature [55]. In addition to these NOEs the 
medium range NOEs of the type C,°H...N ,+ 2H were observed between PhelC°H...Phe-
3 NH and Phe3CaH..,Phe5NH (Figure 2a). These distances are possible only for a 310- 
helical conformation (d = 3.8 A), but not for a-helix (d * 4.2 A) [54,55]. The presence of 
PhelNH.. .Phe3NH and Phe3NH.. .Phe5NH NOEs is a further confirmation of a 310-helical 
structure for this peptide in CDC13 (Figure 2b).
(ii) In (CD3)2 SO :
The intensity pattern of the NOEs in (C D ^SO  (Table 2) is largely similar to the 
one observed in CDCI3. The Nf H .. .Nf + jH NOEs in (CD3)jSO are observed between all the
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Table 2. Some important NOGs observed in peptides 1 and II and comparison with 
corresponding distances in the crystal structure of a 3 jq-helical peptide Boc-Phe-A-Phe-Val-Phe- 
APhe-Val-OCH3 [33].
Peptide Proton Connectivity NOE"
c d c i3 DMSO
distance(A)b
I Phel NH APhe2 NH M M 2 2-3.0
1 Phel Ca H APhe2 NH M M 2 6-3.4
Phe3 NH W - 3.0-3 5
I APhc2 NH Phe2 NH M W 2 2-3.0
1 Phe3 NH APhe4 NH M M 2.2-3.0
Phe5 NH W -
1 Phe3 Ca H APhe4 NH M M 2 6-3.4
Phc5 NH W - 3.0-3 5
1 APhe4 NH Phc5 NH M M 2.2-3 0
11 A Phel NH Phe2 NH M M 2 .2-3.0
11 Phe2 Ca H Ala3 NH M M 2.6-3 4
APhe4 NH W - 3.0-3.5
11 Ala3 NH APhe4 NH M - 2.2-3 .0
Phe2 NH M M 2 .2-3.0
11 Ala3 C“ H APhe4 NH M M 2.6-3 4
Val5 NH W W 3.0-3.5
aNOEs indicated and characterized on the basis of intensity as S-strong, M-Medium. W-Weak. 
The assessment is done on comparison with intraresidue NOEs in the peptide 
bShows the upper and lower limits of the corresponding distances in the crystal structure of the 
mentioned peptide.
residues in CDC13 (Figure 2d) in addition to 'he C“,H ...NI + ,H (Figure 2c) which are 
expected for a helical conformation but the medium range NOEs are not observed in 
(CDj^SO. This could be due to the effect of viscosity of a more viscous solvent (CDj^SO 
on the (ozc correlation which could result in a decrease in the upper limt of the observable 
distance in the spectra [56].
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Figure 2(c). NlI-CfJfH region of 5U0 MHz 2U-R0ES Y fcpectrum of Pcpnde(l) in (CD,)2SO
B. Ac-APhe-Phc-Ala-APhe-Val-OCHj (II)
(t) InCDCli .
As seen liom Figure 3b the strong N H N H mac ,
chain indicating.' a V hc,ica, c o n f o ^ V , " A d  hT "*  ^
APHcl Nil. Phe2 NH p. 9 N„  ,  "J1541 AU ,hc ^quenual NOEs were observed
NH (Figure 3h, a ' AM NH- APhe4N«  and APhe4 NH...Val5
• i ai c ition to these NOEs the medium range NOEs of the lync C °H N
™  ^  -  -  -  - ..
„  - f a . H ,  L  J n Z Z u X T r Thc“
« A) ,54-55>- w . . n .  ,H v m
observed here is aroond 4.0 A. The NOE pattern observed for this peptide indicates the 
existence of a 3|o-helical conformation.
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Figure 2(d). NH-NH region of 500 MHz 2D-ROESY spectrum of Peplide(l) in (CD3 tjSO.
(ii) In (CU3)2 SO :
Peptide (11) in (C D ^SO  shows a similar NOE pattern (Table 2) as observed in peptide (I). 
The following NOEs of the type N,H.. .Nl+ ,H are observed APhe INH.. .Phc2NH, Phe2NH 
..Ala3NH, AJa3NH...APhe4NH and Phe4NH...VaI5NH (Figure 3d) in addition to the 
C«rH ...N I + ,H NOEs (Figure 3c). The strong C “H ...N ,+ ,H and N,H...N,+1H type NOEs 
arc observed for all residues. The presence of the N.H.. ,N, + ,H NOEs is a strong indication of 
helical conformation. Thus, the conformation of peptide II is quiet similar to that of peptide
(I). This suggests that the peptide (II) also adopts a 3,0-helical conformation in (CD-^SO.
3.1.3. Amide accessibility:
In order to determine the hydrogen bonding in peptides, the accessibility of amide protons 
to the solvent was investigated by temperature studies and solvent titration experiments in 
(CDj^SO and CDC13-(CD3)2S0  mixture respectively.
2 1 6 P Sharma and T P Singh
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Figure 3(c). NH-C°H region of 400 MHz 2D-ROESY spectrum of Peptlde(II) in (CDjhSO
Figure 3(d). NH-NH region o f 400 MHz 2D-ROESY spectrum of Peptide(II) in (C D ^ S O .
3.1.4. Temperature dependence studies :
The results of the temperature studies (Table 3) in a solvating media such as (CD3)2SO 
suggested lhat the Phcl and APhc2 in peptide (I) and APhcl and Phe2 in (II) are solvent
Table 3. Amide resonances, temperature coefficients and coupling constants.
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NH resonance 
(residue)
5 (ppm) dSfdT  (ppm/'K) 
DMSO
KHz)
CDCI3 DMSO CDCI3 DMSO
Phel 1 4 25 7.08 0.009 4.70 7 75
APhc2 II 8 98 9 82 0.006 - ...
APhc2 I 7 72 9 80 0 007 - -
Phe2 11 8.15 8 36 0.007 - 8 40
Phe3 I 7 13 8 33 0.0045 6 90 6 15
Alai II 7.75 8.08 0 0035 6 70  ^ 4 50
APhe4 1 8.75 9 69 0 0040 - ’ -
APhe4 II 8 67 9.56 0 0038 -
Val5 1 7 30 &I7 0.004 3 45 7.20
Phe5 11 7 40 7 80 0 0037 _ 7 70
exposed as they show high dS/dT values (> 7 x 10-3 ppm/*K) whereas the remaining 
three residues m both peptides seem to be solvent sheilded because the temperature 
coefficients are in the range 4-5 x 10 J ppm/°K [57]. Thus Phe3 bftl, APhe4 NH, 
Phe5 NH in peptide (I) and Ala3 NH, APhe4 NH, Val5 NH in peptide (II) seem to be 
involved in intramolecular hydrogen bonding. It is also indicative of the formation of a 
4 —* 1 hydrogen bond as observed in the 3|0-helical conformation. Some of the d5/dT 
values are intermediate, suggesting the existence of weaker hydrogen bonds [58]. This 
phenomenon has also been observed in the case of crystal structures of small helical 
peptides 134]
3.1.5. Solvent titration studies :
The change in the chemical shifts was monitored on increase in the concentration of a polar 
solvent (CD3)2SO in the solution of the peptides in CDC13. As evident from the curves in 
Figures 4a and 4b. the changes for Phe3 NH, APhe4 NH, Phe5 NH in peptide (I) and Ala3 
NH, APhc4 NH, Val5 NH in peptide (II) are nominal as compared to the other amides in 
these peptides This suggests that these amide protons are solvent shielded and are involved 
in a 4 1 type of hydrogen bonding [59]. Thus both the temperature dependence and
solvent titration studies indicate hydrogen bonding scheme compatible with 3|0-helical 
structure (Figure 5).
The spin-spin coupling constants are crude indicators of the conformation of small peptides 
but some idea of 0 values can be obtained from the UNH C"H a values for different amides. 
The vicinal coupling constants have an expected value of 4.2 Hz for 3|o-helix (0 = -60°) 
160]. The coupling constants forPhel NH and Phe5 NH are very small (-4  Hz) which suggest
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3J .6 . Spin-spin coupling constants :
1 0 0,
Figure 4(a). Solvcni titration curve ol Pcptide(l) Figure 4(h). Solvent liuntion curve of Peplide(ll)
B oc -  P ^ e  
N
APhe -  P°<? "  0CH3 
N
N-AC —
N
0 0 
I-APhe — Vat -  OCH3 
N
Figure 5. The hydrogen bonding scheme in Pcptides(f) and (It).
a 0 value of —65° indicating the peptide to be folded. In (CDj^SO, these values are 
intermediate for both peptides I and II (~ 7.0 Hz) which can be considered in the range oi 
helical conformation (0 = -7O°).
7()B(3)-8
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4. Conclusions
The results of these investigations suggest that
1. The conformations of APhe containing peptides are similar in both polar and 
nonpolar media.
2 The sequences containing more than one APhe residues which are seperated by a 
saturated residue adopt a 3|0-helical conformation in solution.
3 The sequences containing more than one APhe residues which are seperated by two 
saturated residues, also result in a 3|o-helical structure in solution.
4. The APhe containing peptides adopt similar structures in solution as well as in the 
solid slate |29-36].
These results indicate that the APhe is a strong inducer of specific secondary structures in 
peptides. Therefore the APhe residue offers a powerful design tool to produce specific 
conformations in peptides. ^
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